Simon Hayward
Last active: 2/19/2015

  1. Tumor-secreted Hsp90 subverts polycomb function to drive prostate tumor growth and invasion. Nolan KD, Franco OE, Hance MW, Hayward SW, Isaacs JS (2015) J Biol Chem 290(13): 8271-82
    › Primary publication · 25670862 (PubMed) · PMC4375482 (PubMed Central)
  2. Stretching fibroblasts remodels fibronectin and alters cancer cell migration. Ao M, Brewer BM, Yang L, Franco Coronel OE, Hayward SW, Webb DJ, Li D (2015) Sci Rep : 8334
    › Primary publication · 25660754 (PubMed) · PMC4321168 (PubMed Central)
  3. Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression. Jin R, Yamashita H, Yu X, Wang J, Franco OE, Wang Y, Hayward SW, Matusik RJ (2015) Oncogene 34(28): 3700-10
    › Primary publication · 25220414 (PubMed) · PMC4362792 (PubMed Central)
  4. Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy. Gangadhariah MH, Luther JM, Garcia V, Paueksakon P, Zhang MZ, Hayward SW, Love HD, Falck JR, Manthati VL, Imig JD, Schwartzman ML, Zent R, Capdevila JH, Pozzi A (2015) J Am Soc Nephrol 26(3): 597-610
    › Primary publication · 25071086 (PubMed) · PMC4341468 (PubMed Central)
  5. Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network. Lin-Tsai O, Clark PE, Miller NL, Fowke JH, Hameed O, Hayward SW, Strand DW (2014) Prostate 74(6): 669-79
    › Primary publication · 24500928 (PubMed) · PMC4160824 (PubMed Central)
  6. Stromal androgen receptor in prostate development and cancer. Singh M, Jha R, Melamed J, Shapiro E, Hayward SW, Lee P (2014) Am J Pathol 184(10): 2598-607
    › Primary publication · 25088980 (PubMed) · PMC4188859 (PubMed Central)
  7. SOX2 expression in the developing, adult, as well as, diseased prostate. Yu X, Cates JM, Morrissey C, You C, Grabowska MM, Zhang J, DeGraff DJ, Strand DW, Franco OE, Lin-Tsai O, Hayward SW, Matusik RJ (2014) Prostate Cancer Prostatic Dis 17(4): 301-9
    › Primary publication · 25091041 (PubMed) · PMC4227931 (PubMed Central)
  8. Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis. San Martin R, Barron DA, Tuxhorn JA, Ressler SJ, Hayward SW, Shen X, Laucirica R, Wheeler TM, Gutierrez C, Ayala GE, Ittmann M, Rowley DR (2014) Am J Pathol 184(6): 1860-70
    › Primary publication · 24713391 (PubMed) · PMC4044710 (PubMed Central)
  9. FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype. DeGraff DJ, Grabowska MM, Case TC, Yu X, Herrick MK, Hayward WJ, Strand DW, Cates JM, Hayward SW, Gao N, Walter MA, Buttyan R, Yi Y, Kaestner KH, Matusik RJ (2014) Lab Invest 94(7): 726-39
    › Primary publication · 24840332 (PubMed) · PMC4451837 (PubMed Central)
  10. F2-isoprostanes as a biomarker of oxidative stress in the mouse bladder. Clayton DB, Stephany HA, Ching CB, Rahman SA, Tanaka ST, Thomas JC, Pope JC, Adams MC, Brock JW, Clark PE, Hayward SW, Matusik RJ, Milne GL (2014) J Urol 191(5 Suppl): 1597-601
    › Primary publication · 24679873 (PubMed)